Hang Seng mixed as China inflation rises but deflation worries linger
HKG33 finds support after consumer prices accelerated in November, but deflation fears persist
Page 2 of 5
HKG33 finds support after consumer prices accelerated in November, but deflation fears persist
China's leaders confirmed recent policy shifts aimed at boosting growth, focusing on higher government spending, long-term bonds, and lower interest rates. A 5% growth target is expected for next year, with more details to be revealed in March.
The victory of Donald Trump in last week’s elections send Wall Street soaring, with US 2000 outperforming the broader SPX500
HKG33 is tepid as Chinese authorities announced new fiscal support, but the lack of details and soft inflation report sustain skepticism
The Chinese central bank announced a series of measures to support the economy and stock markets, sending HKG33 to one of its best days of the year
Unlike the last decision that had caused the stock market to plunge, today's cautious pause by the Japanese central bank, saw muted JPN225 reaction and weekly gains
Tech optimism returned after Nvidia CEO offered upbeat AI message, helping NAS100 looks past upside surprise in core CPI
The tech-heavy index posted its worst week of the year and re-entered correction territory after a negative reaction to the NFPs, as markets await Wednesday’s inflation update
Yesterday, the S&P 500 fell for a third consecutive session as markets await today's key August jobs report, which could influence the Federal Reserve’s upcoming interest rate decision. Broadcom’s disappointing revenue guidance and concerns over the AI rally added to market jitters.
The tech-heavy index is on the verge of correction, as Nvidia suffered heavy losses and weak PMIs reignite recession fears, ahead of Friday’s jobs report
Biotech stocks are showing signs of recovery, supported by expected rate cuts and bullish technical indicators. The sector's improving fundamentals could provide a strong boost to the broader healthcare market.
These materials constitute marketing communication and do not take into consideration your personal circumstances, investment experience or current financial situation. The content is provided as general market commentary and should not be construed as containing any type of investment advice, investment recommendation and/or a solicitation for any investment transactions. This market communication does not imply or impose an obligation on you to perform an investment transaction and/or purchase investment products or services. These materials have not been prepared in accordance with legal requirements designed to promote the independence of investment research and are not subject to any prohibition on dealing ahead of the dissemination of investment research.
FXCM, and any of its Affiliates, shall not in any way be liable to you for any inaccuracies, errors or omissions, regardless of cause, in the content of these materials, or for any damages (whether direct or indirect) which may arise from the use of such materials, services and their content. Consequently, any person acting on them does so entirely at their own risk. Please ensure that you read and understand our Full Disclaimer and Liability provision concerning the foregoing Information, which can be accessed here.